At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...

So in summary, HER2CLIMB-05 was a positive study. It showed that adding tucatinib for both HR-positive as well as HR-negative ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

Disrupted sleep, rising stress levels and central obesity are emerging as major drivers of India's growing breast cancer ...

Bang Bang” singer Jessie J, 37, has been center stage this year not just for her performances, but because she’s sharing her ...

A tiny needle system that sends cancer drugs directly into breast cancer cells, while protecting healthy ones, has been ...

Integrative oncology combines standard cancer treatments with complementary therapies to manage symptoms and improve ...

Enhertu showed improved iDFS over Kadcyla in early-stage HER2-positive breast cancer with residual disease post-neoadjuvant ...

Breast cancer, the number one female cancer in Korea, is divided into several types depending on the presence or absence of ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. | Hologic put forward another study that bolsters the use ...

Use of MHT following menopause is not associated with an increased risk for breast cancer among BRCA1 and BRCA2 carriers.

The actress opened up about the importance of connection and community at the San Antonio Breast Cancer Symposium with ...